Loading…
for educational and safety purposes
25I-NBOMe and 25B-NBOMe both come up in the same conversations; they overlap on Serotonin. 25I-NBOMe: 25I-NBOMe is the N-(2-methoxybenzyl) derivative of 2C-I and the best-known member of the NBOMe family, sometimes sold on blotter paper as "N-bomb." The 2-methoxybenzyl substitution raises 5-HT2A receptor affinity into the sub-nanomolar range and yields a highly potent full agonist, a property exploited in neuroscience through its radiolabeled analogue 11C-CIMBI-5, used as a 5-HT2A agonist radioligand for positron-emission-tomography imaging of the receptor's active state. 25B-NBOMe: 25B-NBOMe is the N-(2-methoxybenzyl) derivative of 2C-B and one of the more potent members of the NBOMe family of hallucinogens.
25I-NBOMe is the N-(2-methoxybenzyl) derivative of 2C-I and the best-known member of the NBOMe family, sometimes sold on blotter paper as "N-bomb." The 2-methoxybenzyl substitution raises 5-HT2A receptor affinity into the sub-nanomolar range and yields a highly potent full agonist, a property exploited in neuroscience through its radiolabeled analogue 11C-CIMBI-5, used as a 5-HT2A agonist radioligand for positron-emission-tomography imaging of the receptor's active state. Pharmacological studies attribute its hallucinogenic activity and its effects on cortical dopamine, serotonin, and glutamate release chiefly to 5-HT2A with a contribution from 5-HT2C, and it is metabolized largely by CYP3A4. The compound is essentially inactive orally and is taken sublingually; a large clinical and forensic literature documents numerous poisonings and deaths, frequently after it was mis-sold as LSD, as well as persistent sequelae such as hallucinogen-persisting perception disorder.
25B-NBOMe is the N-(2-methoxybenzyl) derivative of 2C-B and one of the more potent members of the NBOMe family of hallucinogens. Addition of the 2-methoxybenzyl group produces a large increase in 5-HT2A receptor binding affinity, reaching sub-nanomolar values, and yields a high-efficacy agonist that drives the head-twitch response used as a rodent proxy for hallucinogenic activity. The compound undergoes extensive first-pass metabolism and is essentially inactive orally, so it is used sublingually and is commonly sold on blotter paper at very small doses. Its narrow margin between active and toxic doses has been reflected in analytically confirmed severe intoxications featuring agitation, seizures, hyperthermia, and rhabdomyolysis, and in vitro work additionally reports reactive-oxygen-mediated genotoxicity.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
agonist
agonist
agonist
agonist
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.